ADVERTISEMENT
Posted: Dec 7, 2021

Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes

Polypharmacy

Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults.

Loren Bonner

Read more
Posted: Dec 7, 2021

FDA approves new prescription medication for dry eye disease

New Drug

In October 2021, FDA announced the approval of Tyrvaya, a first-inclass medication to treat the signs and symptoms of dry eye disease.

Johanna Taylor Katroscik, PharmD

Read more
Posted: Dec 7, 2021

Brain-boosting supplements… do they work?

On The Shelf

According to a 2019 Brain Health and Dietary Supplements Survey conducted by AARP, over 25% of Americans age 50 and up use some sort of supplement to help boost their brain health.

Johanna Taylor Katroscik, PharmD

Read more
Posted: Dec 7, 2021

Insomnia

OTCs Today

Welcome to 2022! As we continue to navigate stressful and uncertain times, an issue such as insomnia—normally a fairly common complaint— will become even more prevalent.

Daniel L. Krinsky, BS, MS, RPh, FAPhA

Read more
Posted: Dec 7, 2021

New and Approved

Updates from FDA

Updates from FDA

APhA Staff

Read more
First5960616264666768Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT